Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination therapy of Hormone, Paclitaxel
and Radiation therapy are effective in treatment of locally advanced prostate cancer
Phase:
Phase 1
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health